Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Corrigendum
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,072 | Dovepress* | 4,020+ | 79 | 4,099 | |
| PubMed Central* | 52 | 41 | 93 | ||
| Totals | 4,072 | 120 | 4,192 | ||
| *Since 27 October 2022 | |||||
View citations on PubMed Central and Google Scholar